Trial · NCT02205814
Results by group48
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 48
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in WOMAC A | Fasitibant Low Dose | Week 1 after randomisation | -91.8 | Standard Deviation 101.85 | units on a scale |
| Change in WOMAC A | Fasitibant Intermediate Dose | Week 1 after randomisation | -110.0 | Standard Deviation 99.48 | units on a scale |
| Change in WOMAC A | Fasitibant High Dose | Week 1 after randomisation | -109.8 | Standard Deviation 94.65 | units on a scale |
| Change in WOMAC A | PLACEBO | Week 1 after randomisation | -93.7 | Standard Deviation 94.15 | units on a scale |
| Change in WOMAC A | Fasitibant Low Dose | Week 2 after randomisation | -106.1 | Standard Deviation 101.88 | units on a scale |
| Change in WOMAC A | Fasitibant Intermediate Dose | Week 2 after randomisation | -131.5 | Standard Deviation 96.41 | units on a scale |
| Change in WOMAC A | Fasitibant High Dose | Week 2 after randomisation | -115.9 | Standard Deviation 104.61 | units on a scale |
| Change in WOMAC A | PLACEBO | Week 2 after randomisation | -117.2 | Standard Deviation 90.15 | units on a scale |
| Change in WOMAC INDEX | Fasitibant Low Dose | Week 1 after randomisation | -396.0 | Standard Deviation 464.24 | units on a scale |
| Change in WOMAC INDEX | Fasitibant Intermediate Dose | Week 1 after randomisation | -460.5 | Standard Deviation 469.68 | units on a scale |
| Change in WOMAC INDEX | Fasitibant High Dose | Week 1 after randomisation | -445.2 | Standard Deviation 424.07 | units on a scale |
| Change in WOMAC INDEX | PLACEBO | Week 1 after randomisation | -413.2 | Standard Deviation 452.04 | units on a scale |
| Change in WOMAC INDEX | Fasitibant Low Dose | Week 2 after randomisation | -448.0 | Standard Deviation 477.95 | units on a scale |
| Change in WOMAC INDEX | Fasitibant Intermediate Dose | Week 2 after randomisation | -563.0 | Standard Deviation 456.71 | units on a scale |
| Change in WOMAC INDEX | Fasitibant High Dose | Week 2 after randomisation | -488.7 | Standard Deviation 480.39 | units on a scale |
| Change in WOMAC INDEX | PLACEBO | Week 2 after randomisation | -517.7 | Standard Deviation 440.75 | units on a scale |
| Change in WOMAC INDEX | Fasitibant Low Dose | week 4 after randomisation | -516.4 | Standard Deviation 513.70 | units on a scale |
| Change in WOMAC INDEX | Fasitibant Intermediate Dose | week 4 after randomisation | -628.4 | Standard Deviation 500.17 | units on a scale |
| Change in WOMAC INDEX | Fasitibant High Dose | week 4 after randomisation | -493.4 | Standard Deviation 513.94 | units on a scale |
| Change in WOMAC INDEX | PLACEBO | week 4 after randomisation | -562.3 | Standard Deviation 487.25 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02205814/results